{
    "root": "d87ff31d-3d0c-4f33-bdf2-7d19191078a8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Potassium Chloride",
    "value": "20250227",
    "ingredients": [
        {
            "name": "POTASSIUM CHLORIDE",
            "code": "660YQ98I10",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32588"
        },
        {
            "name": "HYDROGENATED COTTONSEED OIL",
            "code": "Z82Y2C65EA",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14334"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "POLYVINYL ALCOHOL",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_61995"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        }
    ],
    "indications": {
        "text": "potassium chloride extended-release tablets indicated treatment prophylaxis hypokalemia without metabolic alkalosis , patients dietary management potassium-rich foods diuretic dose reduction insufficient .",
        "doid_entities": [
            {
                "text": "hypokalemia (DOID:4500)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4500"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "monitor serum potassium adjust dosages accordingly ( 2.1 ) serum potassium less 2.5 meq/l , intravenous potassium instead oral supplementation ( 2.1 ) take meals glass water liquid . swallow tablets whole without crushing , chewing sucking . ( 2.1 ) treatment hypokalemia : doses range 40 to100 meq/day divided doses . limit doses 40 meq per dose . ( 2.2 ) prevention hypokalemia : typical dose 20 meq per day . ( 2.2 )",
        "doid_entities": [
            {
                "text": "hypokalemia (DOID:4500)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4500"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "potassium chloride extended-release tablets , usp contain 600 mg 750 mg potassium chloride , usp ( equivalent 8 meq 10 meq respectively ) , provided extended release tablets . table 1 : supplied dose shape color debossment blistercards 30 tablets blistercards 15 tablets blistercards 14 tablets 600 mg ( 8 meq ) round white off-white \u201c yh \u201d \u201c 106 \u201d one side , \u201c 8 \u201d side n/a n/a n/a 750 mg ( 10 meq ) round white off-white \u201c yh \u201d \u201c 105 \u201d one side , \u201c 10 \u201d side 0615-8570-39 0615-8570-05 0615-8570-14 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature . ] protect light moisture . dispense tight container defined usp child-resistant closure .",
    "adverseReactions": "potassium chloride contraindicated patients triamterene amiloride .",
    "indications_original": "Potassium Chloride Extended-Release Tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.",
    "contraindications_original": "Monitor serum potassium and adjust dosages accordingly\n  \n     (2.1) If serum potassium is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation\n  \n     (2.1) Take with meals and with a glass of water or other liquid. Swallow tablets whole without crushing, chewing or sucking.\n  \n     (2.1) Treatment of hypokalemia : Doses range from 40 to100 mEq/day in divided doses. Limit doses to 40 mEq per dose. (2.2) Prevention of hypokalemia : Typical dose is 20 mEq per day. (2.2)",
    "warningsAndPrecautions_original": "Potassium Chloride Extended-Release Tablets, USP contain 600 mg or 750 mg of Potassium Chloride, USP (equivalent to 8 mEq and 10 mEq respectively), and are provided as extended release tablets.\n                  \n                     \u00a0Table 1: How Supplied\n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              Dose\n                           \n                           \n                              Shape\n                           \n                           \n                              Color\n                           \n                           \n                              Debossment\n                           \n                           \n                              \n                                 Blistercards of 30 tablets\n                              \n                           \n                           \n                              \n                                 \n                                    Blistercards of 15 tablets\n                                 \n                              \n                           \n                           \n                              \n                                 Blistercards of 14 tablets\n                              \n                           \n                        \n                        \n                           \n                        \n                        \n                           \u00a0600 mg (8 mEq)\n                           \u00a0Round\n                           \u00a0White to off-white\n                           \u00a0\u201cYH\u201d and \u201c106\u201d on one side, and \u201c8\u201d on the other side\n                           n/a\n                           n/a\n                           n/a\n                        \n                        \n                           \u00a0750 mg (10 mEq)\n                           \u00a0Round\n                           \u00a0White to off-white\n                           \u00a0\u201cYH\u201d and \u201c105\u201d on one side, and \u201c10\u201d on the other side\n                           \u00a00615-8570-39\n                           \u00a00615-8570-05\n                           \u00a00615-8570-14\n                        \n                     \n                  \n                    Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [See USP Controlled Room Temperature.] Protect from light and moisture.\n\n                  Dispense in a tight container as defined in the USP with a child-resistant closure.",
    "adverseReactions_original": "Potassium chloride is contraindicated in patients on triamterene and amiloride.",
    "drug": [
        {
            "name": "Potassium Chloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32588"
        }
    ]
}